Viewing Study NCT00002193


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-25 @ 4:24 AM
Study NCT ID: NCT00002193
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors
Sponsor: Glaxo Wellcome
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 View
None Drug Therapy, Combination View
None HIV Protease Inhibitors View
None RNA, Viral View
None VX 478 View
None Reverse Transcriptase Inhibitors View
None Anti-HIV Agents View
None Viral Load View